Market Place
Sourcing Support
Valneva SE Discloses Share And Voting Rights – March 2026
03 Apr 2026 //
GLOBENEWSWIRE
Valneva Reports Full Year 2025 Audited Financial Results
18 Mar 2026 //
GLOBENEWSWIRE
Valneva To Release 2025 Financial Results On March 18, 2026
09 Mar 2026 //
GLOBENEWSWIRE
Valneva Announces Shares, Voting Rights as of Feb. 28, 2026
06 Mar 2026 //
GLOBENEWSWIRE
Valneva To Participate In Upcoming Investor Conferences
02 Mar 2026 //
GLOBENEWSWIRE
Valneva Reports Preliminary Unaudited 2025 Revenue and Cash
19 Feb 2026 //
GLOBENEWSWIRE
VALNEVA Declaration of shares and voting rights: January 31, 2026
11 Feb 2026 //
GLOBENEWSWIRE
VALNEVA Declaration Of Shares And Voting Rights: January 31, 2026
06 Feb 2026 //
GLOBENEWSWIRE
Valneva To Present At J.P. Morgan Healthcare Conference
09 Jan 2026 //
GLOBENEWSWIRE
Valneva SE: Voting Rights Declaration - Dec 2025
08 Jan 2026 //
GLOBENEWSWIRE
Valneva Reports Shares, Voting Rights as of Nov. 30, 2025
05 Dec 2025 //
GLOBENEWSWIRE
Valneva Terminates 30 Amid Site Closure
01 Dec 2025 //
BIOSPACE
Valneva To Further Consolidate Its Operations In France
26 Nov 2025 //
GLOBENEWSWIRE
Valneva Reveals 9-Month 2025 Financials And Corporate Updates
20 Nov 2025 //
GLOBENEWSWIRE
VALNEVA Declaration Of Shares & Voting Rights: October 31, 2025
05 Nov 2025 //
GLOBENEWSWIRE
VALNEVA Reports Shares And Voting Rights Declaration: Sep 30
06 Oct 2025 //
GLOBENEWSWIRE
Valneva Boosts Financials, Refinances Debt With Pharmakon Advisor
06 Oct 2025 //
GLOBENEWSWIRE
VALNEVA Declaration of Shares and Voting Rights: August 31, 2025
03 Sep 2025 //
GLOBENEWSWIRE
Valneva Reveals Half Year 2025 Financial Results and Updates
12 Aug 2025 //
GLOBENEWSWIRE
Valneva Declaration of Shares and Voting Rights: July 31, 2025
05 Aug 2025 //
GLOBENEWSWIRE
Valneva Declaration of Shares and Voting Rights: June 30, 2025
03 Jul 2025 //
GLOBENEWSWIRE
Valneva Confirms FY 2025 guidance at Annual General Meeting
25 Jun 2025 //
GLOBENEWSWIRE
[Valneva SE] Declaration of shares and voting rights - May 2025
05 Jun 2025 //
GLOBENEWSWIRE
VALNEVA Declaration of shares and voting rights: April 30, 2025
07 May 2025 //
GLOBENEWSWIRE
Valneva SE Shareholding Declaration - March 2025
03 Apr 2025 //
GLOBENEWSWIRE
Valneva Renews Sales Agreement for Existing ATM Program
26 Mar 2025 //
GLOBENEWSWIRE
Valneva Reports 2024 Results and Business Updates
20 Mar 2025 //
GLOBENEWSWIRE
Valneva Declaration of shares and voting rights: Feb 28, 2025
05 Mar 2025 //
GLOBENEWSWIRE
Valneva To Present At TD Cowen & Van Lanschot Kempen Events
03 Mar 2025 //
GLOBENEWSWIRE
Valneva Reports Preliminary Unaudited 2024 Revenue & Cash
18 Feb 2025 //
GLOBENEWSWIRE
Shareholding declaration Valneva SE - January 2025
06 Feb 2025 //
GLOBENEWSWIRE
Valneva to Meet with Investors during the J.P. Morgan Conference
06 Jan 2025 //
GLOBENEWSWIRE
Valneva Declaration of shares and voting rights: Dec 31, 2024
03 Jan 2025 //
GLOBENEWSWIRE
Valneva Declaration of shares and voting rights: Nov 30, 2024
05 Dec 2024 //
GLOBENEWSWIRE
Valneva Publishes Chikungunya Health & Economic Burden in BMJ
04 Dec 2024 //
GLOBENEWSWIRE
Valneva Reports 9 Month 2024 Financial Results & Updates
07 Nov 2024 //
GLOBENEWSWIRE
VALNEVA - Declaration of shares & voting rights: October 31, 2024
06 Nov 2024 //
GLOBENEWSWIRE
Valneva To Present On Chikungunya At Leading Scientific Conferences
21 Oct 2024 //
GLOBENEWSWIRE
Valneva SE - Declaration Of Shares And Voting Rights - September
04 Oct 2024 //
GLOBENEWSWIRE
Valneva Sets NYC Investor Day For October 10 At 10 AM ET
03 Oct 2024 //
GLOBENEWSWIRE
Valneva Raises €60 Million In Private Placement
13 Sep 2024 //
GLOBENEWSWIRE
Valneva Launches €60 Million Private Placement
12 Sep 2024 //
GLOBENEWSWIRE
Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates
12 Aug 2024 //
GLOBENEWSWIRE
VALNEVA - Declaration of shares and voting rights: July 31, 2024
06 Aug 2024 //
GLOBENEWSWIRE
Valneva Pays LimmaTech $10M For Shigella Vaccine
02 Aug 2024 //
FIERCE BIOTECH
CEPI Grants Valneva $41.3M To Expand Access To Chikungunya Vaccine
22 Jul 2024 //
GLOBENEWSWIRE
Valneva And Pfizer Complete Primary Vaccination In Lyme Trial
17 Jul 2024 //
GLOBENEWSWIRE
Declaration of shares and voting rights - Valneva SE - June 30, 2024
04 Jul 2024 //
GLOBENEWSWIRE
Valneva Announces Outcome of General Meeting Appointment of a New Director
26 Jun 2024 //
GLOBENEWSWIRE
VALNEVA - Declaration of shares and voting rights: May 31, 2024
04 Jun 2024 //
GLOBENEWSWIRE
Valneva Q1 2024 Results And Corporate Updates
07 May 2024 //
GLOBENEWSWIRE
Declaration of voting rights - Valneva SE, March 2024
04 Apr 2024 //
GLOBENEWSWIRE
VALNEVA Declaration of shares and voting rights - February 29, 2024
06 Mar 2024 //
GLOBENEWSWIRE
Valneva to Present at Upcoming TD Cowen Healthcare Investor Conferences
04 Mar 2024 //
GLOBENEWSWIRE
Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance
15 Feb 2024 //
GLOBENEWSWIRE
VALNEVA: Declaration of shares and voting rights - January 31, 2024
07 Feb 2024 //
GLOBENEWSWIRE
VALNEVA - Declaration of shares and voting rights: December 31, 2023
05 Jan 2024 //
GLOBENEWSWIRE
VALNEVA Declaration of shares and voting rights - November 30, 2023
06 Dec 2023 //
GLOBENEWSWIRE
Valneva Reports Nine-Month 2023 Financial Results and Provides Corporate Updates
09 Nov 2023 //
GLOBENEWSWIRE
VALNEVA Declaration of shares and voting rights: October 31, 2023
06 Nov 2023 //
GLOBENEWSWIRE
